North Forty Two & Co’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Hold
641
0.65% 43
2026
Q1
$590K Buy
641
+2
+0.3% +$2.03K 0.55% 48
2025
Q4
$687K Hold
639
0.65% 43
2025
Q3
$488K Sell
639
-10
-2% -$7.44K 0.48% 62
2025
Q2
$506K Sell
649
-10
-2% -$7.77K 0.54% 54
2025
Q1
$544K Buy
659
+5
+0.8% +$4.16K 0.6% 50
2024
Q4
$505K Buy
+654
New +$542K 0.58% 49

Other funds holding LLY

North Forty Two & Co's LLY Position: Q2 2026 in Review

North Forty Two & Co held its Eli Lilly (LLY) position steady in Q2 2026 at 641 shares worth $769K. The position accounts for 0.65% of the portfolio, ranked #43.

North Forty Two & Co first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 2,501 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • North Forty Two & Co held 641 shares of Eli Lilly worth $769K as of Q2 2026.
  • North Forty Two & Co left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.65% of North Forty Two & Co's portfolio in Q2 2026, its #43 holding.
  • North Forty Two & Co first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on North Forty Two & Co's 13F filing for Q2 2026, filed 24 Jul 2026.